198 related articles for article (PubMed ID: 27908757)
21. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
22. New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.
Scalese G; Machado I; Fontana C; Risi G; Salinas G; Pérez-Díaz L; Gambino D
J Biol Inorg Chem; 2018 Dec; 23(8):1265-1281. PubMed ID: 30194536
[TBL] [Abstract][Full Text] [Related]
23. Imidazoles from nitroallylic acetates and α-bromonitroalkenes with amidines: synthesis and trypanocidal activity studies.
Gopi E; Kumar T; Menna-Barreto RF; Valença WO; da Silva Júnior EN; Namboothiri IN
Org Biomol Chem; 2015 Oct; 13(38):9862-71. PubMed ID: 26288376
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of
da Silva CF; Batista DDGJ; de Araújo JS; Cunha-Junior EF; Stephens CE; Banerjee M; Farahat AA; Akay S; Fisher MK; Boykin DW; Soeiro MNC
Drug Des Devel Ther; 2017; 11():1095-1105. PubMed ID: 28435221
[TBL] [Abstract][Full Text] [Related]
25. Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease.
de Menezes Dda R; Calvet CM; Rodrigues GC; de Souza Pereira MC; Almeida IR; de Aguiar AP; Supuran CT; Vermelho AB
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):964-73. PubMed ID: 26327246
[TBL] [Abstract][Full Text] [Related]
26. Mammea type coumarins isolated from Calophyllum brasiliense induced apoptotic cell death of Trypanosoma cruzi through mitochondrial dysfunction, ROS production and cell cycle alterations.
Rodríguez-Hernández KD; Martínez I; Reyes-Chilpa R; Espinoza B
Bioorg Chem; 2020 Jul; 100():103894. PubMed ID: 32388434
[TBL] [Abstract][Full Text] [Related]
27. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi.
Rodríguez-Hernández KD; Martínez I; Agredano-Moreno LT; Jiménez-García LF; Reyes-Chilpa R; Espinoza B
Phytomedicine; 2019 Aug; 61():152827. PubMed ID: 31039535
[TBL] [Abstract][Full Text] [Related]
28. A structure-based approach towards the identification of novel antichagasic compounds:
Llanos MA; Sbaraglini ML; Villalba ML; Ruiz MD; Carrillo C; Alba Soto C; Talevi A; Angeli A; Parkkila S; Supuran CT; Gavernet L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):21-30. PubMed ID: 31619095
[No Abstract] [Full Text] [Related]
29. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
32. Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation.
Chao MN; Storey M; Li C; Rodríguez MG; Di Salvo F; Szajnman SH; Moreno SNJ; Docampo R; Rodriguez JB
Bioorg Med Chem; 2017 Dec; 25(24):6435-6449. PubMed ID: 29107437
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Balfour MN; Franco CH; Moraes CB; Freitas-Junior LH; Stefani HA
Eur J Med Chem; 2017 Mar; 128():202-212. PubMed ID: 28189084
[TBL] [Abstract][Full Text] [Related]
34. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
35. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
[TBL] [Abstract][Full Text] [Related]
36. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
[TBL] [Abstract][Full Text] [Related]
37. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease.
Marín C; Ramírez-Macías I; López-Céspedes A; Olmo F; Villegas N; Díaz JG; Rosales MJ; Gutiérrez-Sánchez R; Sánchez-Moreno M
J Nat Prod; 2011 Apr; 74(4):744-50. PubMed ID: 21466157
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma cruzi Agents.
Bollini M; Bruno AM; Niño ME; Casal JJ; Sasiambarrena LD; Valdez DAG; Battini L; Puente VR; Lombardo ME
Med Chem; 2019; 15(3):265-276. PubMed ID: 30295191
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
